Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • FitzGerald, J Mark
  • Bleecker, Eugene R
  • Nair, Parameswaran Krishna
  • Korn, Stephanie
  • Ohta, Ken
  • Lommatzsch, Marek
  • Ferguson, Gary T
  • Busse, William W
  • Barker, Peter
  • Sproule, Stephanie
  • Gilmartin, Geoffrey
  • Werkstrom, Viktoria
  • Aurivillius, Magnus
  • Goldman, Mitchell

publication date

  • October 29, 2016